BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 26867490)

  • 1. IL-6 pathway in the liver: From physiopathology to therapy.
    Schmidt-Arras D; Rose-John S
    J Hepatol; 2016 Jun; 64(6):1403-15. PubMed ID: 26867490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration.
    Drucker C; Gewiese J; Malchow S; Scheller J; Rose-John S
    J Autoimmun; 2010 Feb; 34(1):29-37. PubMed ID: 19717281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and its receptor: from bench to bedside.
    Scheller J; Rose-John S
    Med Microbiol Immunol; 2006 Dec; 195(4):173-83. PubMed ID: 16741736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling.
    Malchow S; Thaiss W; Jänner N; Waetzig GH; Gewiese-Rabsch J; Garbers C; Yamamoto K; Rose-John S; Scheller J
    Biochim Biophys Acta; 2011 Mar; 1812(3):290-301. PubMed ID: 21130161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 trans-signaling in inflammatory bowel disease.
    Mitsuyama K; Sata M; Rose-John S
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):451-61. PubMed ID: 17045835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6--a key regulator of colorectal cancer development.
    Waldner MJ; Foersch S; Neurath MF
    Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
    Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
    Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 and related cytokines: effect on the acute phase reaction.
    Heinrich PC; Horn F; Graeve L; Dittrich E; Kerr I; Müller-Newen G; Grötzinger J; Wollmer A
    Z Ernahrungswiss; 1998; 37 Suppl 1():43-9. PubMed ID: 9558728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
    Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
    J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 signaling in liver progenitor cell migration and proliferation.
    Yeoh GC; Ernst M; Rose-John S; Akhurst B; Payne C; Long S; Alexander W; Croker B; Grail D; Matthews VB
    Hepatology; 2007 Feb; 45(2):486-94. PubMed ID: 17256754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of interleukin-6 signaling in nervous tissue.
    Rothaug M; Becker-Pauly C; Rose-John S
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1218-27. PubMed ID: 27016501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J; Ohnesorge N; Rose-John S
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S11-5. PubMed ID: 17708739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regenerative activity of interleukin-6.
    Galun E; Rose-John S
    Methods Mol Biol; 2013; 982():59-77. PubMed ID: 23456862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
    Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
    J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6.
    Hu F; Nicholas J
    J Virol; 2006 Nov; 80(21):10874-8. PubMed ID: 16956953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and its receptors: a highly regulated and dynamic system.
    Wolf J; Rose-John S; Garbers C
    Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.